AZN vs SXI · P/E 28, $288.38B cap vs P/E 35, rev $891.6M
AstraZeneca PLC (AZN) versus Standex International Corporation (SXI) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Standex International Corporation (SXI) is a specialty industrial machinery company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported SXI revenue for 2026-06-30 was $891.6M. Net income was $104.6M. Revenue was up 12.8% from 2025-06-30 to 2026-06-30. SXI currently screens at market cap $3.52B and trailing P/E 35.3.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SXI currently screens at market cap $3.52B and trailing P/E 35.3.
Not investment advice. Open the AZN and SXI stock pages for the full models.
Not investment advice.